Natrix Separations Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Natrix Separations Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013925
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies is a medical device company that provides disposable products. The company’s products line comprise HD-Q membrane adsorbers and bind-elute products. Its HD-Q membrane adsorbers finds application in single-use flow-through polish applications; and bind-elute products in downstream bind-elute operations. Natrix supplies multi-cycle disposable chromatography products for life science, food, beverage and water markets. The company HD membrane technology offers breakthrough in membrane architecture that changes downstream purification. It markets products through a network of distributors in Europe, North America and Asia. Natrix Separation is headquartered in Burlington, Ontario, Canada.

Natrix Separations Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Natrix Separations Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Natrix Separations Enters into Co-Development Agreement with Merck and Sanofi 9
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 10
Acquisition 11
Merck to Acquire Natrix Separations 11
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 12
Natrix Separations Inc – Key Competitors 13
Natrix Separations Inc – Key Employees 14
Natrix Separations Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Natrix Separations Inc, Pharmaceuticals & Healthcare, Key Facts 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Natrix Separations Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Natrix Separations Enters into Co-Development Agreement with Merck and Sanofi 9
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 10
Merck to Acquire Natrix Separations 11
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 12
Natrix Separations Inc, Key Competitors 13
Natrix Separations Inc, Key Employees 14

★海外企業調査レポート[Natrix Separations Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ben E. Keith Company:戦略・SWOT・企業財務分析
    Ben E. Keith Company - Strategy, SWOT and Corporate Finance Report Summary Ben E. Keith Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Rallye SA:戦略・SWOT・企業財務分析
    Rallye SA - Strategy, SWOT and Corporate Finance Report Summary Rallye SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Empire Co Ltd:戦略・SWOT・企業財務分析
    Empire Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Empire Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Power Climber Wind:企業の戦略的SWOT分析
    Power Climber Wind - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Oshkosh Corporation:企業の戦略・SWOT・財務情報
    Oshkosh Corporation - Strategy, SWOT and Corporate Finance Report Summary Oshkosh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Do & Co Poland Sp.Z.O.O:企業の戦略・SWOT・財務分析
    Do & Co Poland Sp.Z.O.O - Strategy, SWOT and Corporate Finance Report Summary Do & Co Poland Sp.Z.O.O - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Simply Energy:企業の戦略的SWOT分析
    Simply Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Kuros Biosciences AG (KURN):医療機器:M&Aディール及び事業提携情報
    Summary Kuros Biosciences AG (Kuros Biosciences) is a developer of products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as we …
  • Glidewell Laboratories:企業の戦略的SWOT分析
    Glidewell Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Dimension Data Holdings Plc:企業の戦略的SWOT分析
    Dimension Data Holdings Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Envipco Holding NV (ENVI):企業の財務・戦略的SWOT分析
    Envipco Holding NV (ENVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • aap Implantate AG (AAQ):企業の製品パイプライン分析2018
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • Veritas (India) Ltd:企業の戦略・SWOT・財務分析
    Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ABB Ltd (ABBN):企業の財務・戦略的SWOT分析
    ABB Ltd (ABBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Lake Region Electric Cooperative, Inc.:発電所・企業SWOT分析
    Lake Region Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • Great Western Oil & Gas Co LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Great Western Oil & Gas Co LLC (GWOG), a subsidiary of The Broe Group, is an oil and gas company that offers exploration and production of oil and gas properties. The company operates through developmental drilling, and corporate and property acquisition operations. Its core area of operatio …
  • Compal Electronics, Inc.:企業の戦略・SWOT・財務情報
    Compal Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Compal Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Chemetall GmbH:企業の戦略的SWOT分析
    Chemetall GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • GulfMark Offshore Inc (GLF):石油・ガス:M&Aディール及び事業提携情報
    Summary GulfMark Offshore Inc (GulfMark Offshore), formerly New GulfMark Offshore Inc is an oil and gas company that offers oil and gas, and marine transportation services. The company owns, operates, and manages fleet of vessels offering marine specialty services to offshore oil and natural gas dri …
  • enGene Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary enGene Inc (enGene) is a biotechnology company that focuses on transforming medicine by administering gene therapy as an oral drug. The company develops a mucosal immunotherapy platform for treating inflammatory bowel disease and diabetes. It also developed a non-viral gene-therapy platform …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆